AAAAAA

   
Results: 1-12 |
Results: 12
Neurological symptoms during primary human immunodeficiency virus (HIV) infection correlate with high levels of HIV RNA in cerebrospinal fluid
Authors: Tambussi, G Gori, A Capiluppi, B Balotta, C Papagno, L Morandini, B Di Pietro, M Ciuffreda, D Saracco, A Lazzarin, A
Citation: G. Tambussi et al., Neurological symptoms during primary human immunodeficiency virus (HIV) infection correlate with high levels of HIV RNA in cerebrospinal fluid, CLIN INF D, 30(6), 2000, pp. 962-965
Anti-cell antibodies in exposed seronegative individuals with HIV type 1-neutralizing activity
Authors: Lopalco, L Pastori, C Cosma, A Burastero, SE Capiluppi, B Boeri, E Beretta, A Lazzarin, A Siccardi, AG
Citation: L. Lopalco et al., Anti-cell antibodies in exposed seronegative individuals with HIV type 1-neutralizing activity, AIDS RES H, 16(2), 2000, pp. 109-115
Viral dynamics and mutations in the pol gene during primary HIV-1 infection
Authors: Cenci, A Bertoli, A Tambussi, G Menzo, S Clementi, M Lazzarin, A Capiluppi, B Ciuffreda, D Forbici, F Aquaro, S Marcuccilli, F Calio, R Perno, CF
Citation: A. Cenci et al., Viral dynamics and mutations in the pol gene during primary HIV-1 infection, J BIOL REG, 14(1), 2000, pp. 7-10
Four drug-HAART in primary HIV-1 infection: clinical benefits and virologic parameters
Authors: Capiluppi, B Ciuffreda, D Quinzan, GP Sciandra, M Marroni, M Morandini, B Costigliola, P Guerra, L Di Pietro, M Fibbia, GF Visona, R Cusini, M Bressi, C Tambussi, G Lazzarin, A
Citation: B. Capiluppi et al., Four drug-HAART in primary HIV-1 infection: clinical benefits and virologic parameters, J BIOL REG, 14(1), 2000, pp. 58-62
Primary HIV infection: molecular approaches in diagnosis and monitoring
Authors: Ciuffreda, D Capiluppi, B Mastrorilli, E Balconi, G Tambussi, G Lazzarin, A Lillo, F
Citation: D. Ciuffreda et al., Primary HIV infection: molecular approaches in diagnosis and monitoring, J BIOL REG, 14(1), 2000, pp. 63-67
Early production of HIV-1 neutralising antibodies in patients following highly active antiretroviral treatment (HAART) during primary HIV infection
Authors: Barassi, C De Santis, C Pastori, C Marraccini, P Ciuffreda, D Capiluppi, B Bressi, C Siccardi, AG Lazzarin, A Tambussi, G Lopalco, L
Citation: C. Barassi et al., Early production of HIV-1 neutralising antibodies in patients following highly active antiretroviral treatment (HAART) during primary HIV infection, J BIOL REG, 14(1), 2000, pp. 68-74
Analysis of serum and plasma beta chemokines in primary HIV infection (PHI)
Authors: Malnati, MS Tambussi, G Fischetti, L Algeri, M Veglia, F Capiluppi, B Lazzarin, A Lusso, P
Citation: Ms. Malnati et al., Analysis of serum and plasma beta chemokines in primary HIV infection (PHI), J BIOL REG, 14(1), 2000, pp. 75-78
Cyclosporin A in combination with HAART in primary HIV-1 infection
Authors: Rizzardi, GP Vaccarezza, M Capiluppi, B Tambussi, G Lazzarin, A Pantaleo, G
Citation: Gp. Rizzardi et al., Cyclosporin A in combination with HAART in primary HIV-1 infection, J BIOL REG, 14(1), 2000, pp. 79-81
Metabolic disorders in a cohort of patients treated with highly aggressiveantiretroviral therapies during primary HIV-1 infection
Authors: Capiluppi, B Ciuffreda, D Sciandra, M Marroni, M Tambussi, G Lazzarin, A
Citation: B. Capiluppi et al., Metabolic disorders in a cohort of patients treated with highly aggressiveantiretroviral therapies during primary HIV-1 infection, AIDS, 14(12), 2000, pp. 1861-1862
First report of the presence of human T-cell lymphotropic virus I infection in Italian drug addicts
Authors: Lillo, FB Capiluppi, B Chiarolini, A McDermott, JL Varnier, OE
Citation: Fb. Lillo et al., First report of the presence of human T-cell lymphotropic virus I infection in Italian drug addicts, EUR J CL M, 18(9), 1999, pp. 671-672
The rationale for a study on HIV-1 reverse transcriptase mutations and outcome of antiretroviral therapy with two nucleoside analogs
Authors: Gianotti, N Moretti, F Tambussi, G Capiluppi, B Ferrari, M Lazzarin, A
Citation: N. Gianotti et al., The rationale for a study on HIV-1 reverse transcriptase mutations and outcome of antiretroviral therapy with two nucleoside analogs, J BIOL REG, 13(3), 1999, pp. 158-162
Viral load and burden modification following early antiretroviral therapy of primary HIV-1 infection
Authors: Lillo, FB Ciuffreda, D Veglia, F Capiluppi, B Mastrorilli, E Vergani, B Tambussi, G Lazzarin, A
Citation: Fb. Lillo et al., Viral load and burden modification following early antiretroviral therapy of primary HIV-1 infection, AIDS, 13(7), 1999, pp. 791-796
Risultati: 1-12 |